Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.870
+0.030 (1.63%)
Nov 28, 2025, 1:00 PM EST - Market closed
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $297.58 million as of November 28, 2025. Its market cap has decreased by -53.14% in one year.
Market Cap
297.58M
Enterprise Value
249.28M
1-Year Change
-53.14%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $297.58M, an increase of 138.38%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 297.58M | -45.11% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |